RecensMedical Inc

RecensMedical Inc has a market capitalization of KRW 298.93 billion and a price-to-book ratio of 42.84, indicating a high valuation relative to its book value. The company's liquidity position is characterized by a current ratio of 2.69, suggesting it has sufficient short-term assets to cover its liabilities. However, the company's operating cash flow is negative at KRW -8.59 billion, and its free cash flow is also negative at KRW -19.42 billion, indicating a lack of cash generation from operations. Profitability metrics show that the company is currently unprofitable, with a net income of KRW -19.12 billion and an operating income of KRW -10.64 billion. The return on equity is -2.74%, and the return on assets is -1.59%, both significantly below the industry median for medical equipment and supplies. The company's gross profit margin is 49.07%, which is in line with the industry median, but its operating margin is -120.53%, indicating a severe underperformance in controlling operating expenses. The company's revenue is concentrated in a few key markets, with the domestic market being the primary source of revenue. The geographic exposure is not fully disclosed, but the international market is mentioned as a secondary revenue stream. The company's product portfolio is focused on medical devices, with no significant diversification into other healthcare services or equipment. The company's growth trajectory is currently negative, with a net income decline of 100% year-over-year. The outlook for the current fiscal year indicates a continuation of losses, with no significant improvement in revenue or profitability expected. The company's capital expenditure of KRW -806.84 million suggests a reduction in investment in new projects or equipment, which may impact future growth. The company's risk assessment indicates a medium liquidity risk and a low dilution risk. The key flag of negative net cash after subtracting total debt highlights the company's cash flow challenges. The dilution potential is low, with no significant changes in shares outstanding between basic and diluted shares. The company's debt-to-equity ratio of 0.12 suggests a conservative capital structure, but the negative operating cash flow and free cash flow indicate a need for external financing. Recent events and filings have not been disclosed in the provided data, but the company's financial performance and risk profile suggest a need for close monitoring of its cash flow and profitability. The company's ability to generate positive cash flow from operations will be critical to its long-term sustainability.